Australian shares posted their biggest intra-day gain in more than three weeks on Friday, led by financials and healthcare stocks and clawing back this week’s earlier losses, as investors eyed the possibility of an imminent U.S. healthcare vote. The market has continued to recover from the 90-point fall on Wednesday,[Read More…]

Officials are giving consumers two more business days to sign up. USA Today: Feds Extend Healthcare.Gov Deadline To Dec. 19, Citing Late RushFederal regulators Thursday night extended the midnight deadline for Affordable Care Act insurance by four days, as consumers fought to get through to call center operators and log[Read More…]

The battle over rising drug prices has become a full-blown he-said-she-said. Drug companies have pointed the finger at middlemen in the health-care system, saying they not only benefit from rising drug prices but contribute to their increases. Those middlemen — namely, pharmacy benefits managers (or PBMs) — have said the[Read More…]

A team of scientists determined the structure of an ion channel and the potential mechanisms leading to the activation of a mutated gene in autosomal dominant polycystic kidney disease. A new study published in the journal Cell provides insight into potential mechanisms for the activation of a mutated gene in[Read More…]

It’s crossover week at Industry Focus! In this week’s Financials edition, Motley Fool analyst Gaby Lapera talks with Motley Fool healthcare bureau chief Michael Douglass about healthcare sector real estate investment trusts. The duo explains what REITs are, why investors might want to have some in their portfolio, one area[Read More…]